The immunoregulatory potential of CD101 was further strengthened by a subsequent study involving graft versus host disease, in which they manifested that an elevated expression level of CD101 on Tregs was associated with an increased capacity in restraining effector T cells. The gene discussed is CD101; the disease is graft versus host disease.